For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was ...
The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with almost 17,000 ...
As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.
Chlorination is a widely used method to disinfect drinking water, but new research suggests its byproducts may pose cancer ...
Additional data from CheckMate 274 showed that adjuvant nivolumab benefits patients with muscle-invasive bladder cancer with ...
A recent study links long-term consumption of chlorinated water to higher risks of cancers, including bladder, colorectal, and kidney cancer. It highl ...
Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...
What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...
FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.
Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...
ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results